EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma

Masatake Kanai, Aiko Sakai, Tomoko Date, Yoshihiko Aoki, Fuminori Mihara, Takashi Kokudo, Fuyuki Inagaki, Nobuyuki Takemura, Norihiro Kokudo, Masaya Sugiyama iD

Journal of Gastroenterology · 2026-08 · 61 (8) · 1146-1158

DOI: 10.1007/s00535-026-02433-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 30.04.2026. Verfasst von Masatake Kanai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, 162-8655…. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms, Fibrinogen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, National Center for Global Health and Medicine Intramural Research Fund, Japan Institute for Health Security.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatitis B virus (HBV) infection remains a leading cause of hepatocellular carcinoma (HCC), yet the molecular mechanisms underlying HBV-mediated hepatocarcinogenesis are not fully understood. This study focused on miR-4461, which is encoded within the intronic region of PCBD2 gene, and investigated its role in HBV-derived HCC. Methods miR-4461 expression was examined in HBV-expressing hepatoma cell lines and in HBV-infected primary human hepatocytes. Functional analysis evaluated the effects of miR-4461 overexpression or inhibition on hepatocyte proliferation. Candidate targets were screened, and fibrinogen alpha chain (FGA) was tested for regulation by miR-4461. Circulating miR-4461 and plasma FGA were measured in patients with chronic viral hepatitis, including those with HBV-related HCC; in the HBV-HCC cohort, FGA was also assessed before and after surgical tumor resection. Results miR-4461 expression was significantly reduced in HBV-expressing hepatoma cells and HBV-infected primary hepatocytes. Overexpression of miR-4461 inhibited hepatocyte proliferation, whereas its inhibition enhanced proliferation, indicating a tumor-suppressive function. FGA was identified as a downstream target; in hepatoma cells, FGA protein levels were regulated by miR-4461. Clinically, circulating miR-4461 levels were significantly lower in HBV-infected individuals, particularly in those with HBV-related HCC. In contrast, plasma FGA protein levels were markedly elevated in HBV-related HCC and decreased significantly after tumor resection.

Conclusions

These findings suggest a novel regulatory axis in HBV-associated HCC involving HBV-induced suppression of miR-4461 and subsequent upregulation of FGA. Both miR-4461 and FGA were associated with disease status, supporting their potential utility as biomarkers or therapeutic targets in HBV-derived HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCarcinoma, HepatocellularLiver NeoplasmsFibrinogenHepatitis B, ChronicHumansDown-RegulationCell ProliferationHepatocytesFemaleMaleHepatitis B virusCell Line, TumorMiddle AgedGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Fibrinogen alpha chainHepatitis B virusHepatocellular carcinomasMiR-4461

Substanzen

MicroRNAsFibrinogen

Autor:innen und Institutionen

  • Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, 162-8655, Japan.
  • Faculty of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan.
  • Department of Gastroenterology and Hepatology, National Kohnodai Medical Center, Japan Institute for Health Security, Chiba, Japan.
  • Department of Surgery, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
  • Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, 162-8655, Japan. sugiyama.m@jihs.go.jp.

ORCID-Profile: Masaya Sugiyama

Förderung

  • Japan Agency for Medical Research and Development
  • National Center for Global Health and Medicine Intramural Research Fund
  • Japan Institute for Health Security

Zitieren

APA

Kanai, M., Sakai, A., Date, T., Aoki, Y., Mihara, F., Kokudo, T., Inagaki, F., Takemura, N., Kokudo, N., & Sugiyama, M. (2026). HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma. Journal of Gastroenterology, 61(8), 1146-1158. https://doi.org/10.1007/s00535-026-02433-1

Vancouver

Kanai M, Sakai A, Date T, Aoki Y, Mihara F, Kokudo T, et al. HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma. Journal of Gastroenterology. 2026;61(8):1146-1158. doi:10.1007/s00535-026-02433-1

BibTeX
@article{Kanai2026,
  author = {Kanai, Masatake and Sakai, Aiko and Date, Tomoko and Aoki, Yoshihiko and Mihara, Fuminori and Kokudo, Takashi and Inagaki, Fuyuki and Takemura, Nobuyuki and Kokudo, Norihiro and Sugiyama, Masaya},
  title = {HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma},
  journal = {Journal of Gastroenterology},
  year = {2026},
  volume = {61},
  number = {8},
  pages = {1146--1158},
  doi = {10.1007/s00535-026-02433-1}
}
Kostenlos starten →